BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34107271)

  • 1. GPR34-mediated sensing of lysophosphatidylserine released by apoptotic neutrophils activates type 3 innate lymphoid cells to mediate tissue repair.
    Wang X; Cai J; Lin B; Ma M; Tao Y; Zhou Y; Bai L; Jiang W; Zhou R
    Immunity; 2021 Jun; 54(6):1123-1136.e8. PubMed ID: 34107271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolite-Sensing Receptor Ffar2 Regulates Colonic Group 3 Innate Lymphoid Cells and Gut Immunity.
    Chun E; Lavoie S; Fonseca-Pereira D; Bae S; Michaud M; Hoveyda HR; Fraser GL; Gallini Comeau CA; Glickman JN; Fuller MH; Layden BT; Garrett WS
    Immunity; 2019 Nov; 51(5):871-884.e6. PubMed ID: 31628054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-21 Controls ILC3 Cytokine Production and Promotes a Protective Phenotype in a Mouse Model of Colitis.
    Poholek CH; Dulson SJ; Zajac AJ; Harrington LE
    Immunohorizons; 2019 Jun; 3(6):194-202. PubMed ID: 31356165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-17D regulates group 3 innate lymphoid cell function through its receptor CD93.
    Huang J; Lee HY; Zhao X; Han J; Su Y; Sun Q; Shao J; Ge J; Zhao Y; Bai X; He Y; Wang X; Wang X; Dong C
    Immunity; 2021 Apr; 54(4):673-686.e4. PubMed ID: 33852831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysophosphatidylserine suppresses IL-2 production in CD4 T cells through LPS
    Shinjo Y; Makide K; Satoh K; Fukami F; Inoue A; Kano K; Otani Y; Ohwada T; Aoki J
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):332-338. PubMed ID: 29017923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPR34 is a receptor for lysophosphatidylserine with a fatty acid at the sn-2 position.
    Kitamura H; Makide K; Shuto A; Ikubo M; Inoue A; Suzuki K; Sato Y; Nakamura S; Otani Y; Ohwada T; Aoki J
    J Biochem; 2012 May; 151(5):511-8. PubMed ID: 22343749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPR34 as a lysophosphatidylserine receptor.
    Makide K; Aoki J
    J Biochem; 2013 Apr; 153(4):327-9. PubMed ID: 23389307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commensal and Pathogenic Bacteria Indirectly Induce IL-22 but Not IFNγ Production From Human Colonic ILC3s via Multiple Mechanisms.
    Castleman MJ; Dillon SM; Purba CM; Cogswell AC; Kibbie JJ; McCarter MD; Santiago ML; Barker E; Wilson CC
    Front Immunol; 2019; 10():649. PubMed ID: 30984202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-1 regulates ILC3-driven intestinal immunity and homeostasis.
    Jacquelot N; Xiong L; Cao WHJ; Huang Q; Yu H; Sayad A; Anttila CJA; Baldwin TM; Hickey PF; Amann-Zalcenstein D; Ohashi PS; Nutt SL; Belz GT; Seillet C
    Mucosal Immunol; 2024 Jun; 17(3):371-386. PubMed ID: 38492744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGB1 exacerbates experimental mouse colitis by enhancing innate lymphoid cells 3 inflammatory responses via promoted IL-23 production.
    Chen X; Li L; Khan MN; Shi L; Wang Z; Zheng F; Gong F; Fang M
    Innate Immun; 2016 Nov; 22(8):696-705. PubMed ID: 27670944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis.
    Zindl CL; Lai JF; Lee YK; Maynard CL; Harbour SN; Ouyang W; Chaplin DD; Weaver CT
    Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12768-73. PubMed ID: 23781104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidylserine stimulates chemotactic migration of colorectal cancer cells through GPR34 and PI3K/Akt pathway.
    Iida Y; H Tsuno N; Kishikawa J; Kaneko K; Murono K; Kawai K; Ikeda T; Ishihara S; Yamaguchi H; Sunami E; Kitayama J; Yatomi Y; Watanabe T
    Anticancer Res; 2014 Oct; 34(10):5465-72. PubMed ID: 25275042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPR34 in spinal microglia exacerbates neuropathic pain in mice.
    Sayo A; Konishi H; Kobayashi M; Kano K; Kobayashi H; Hibi H; Aoki J; Kiyama H
    J Neuroinflammation; 2019 Apr; 16(1):82. PubMed ID: 30975169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.
    Castellanos JG; Woo V; Viladomiu M; Putzel G; Lima S; Diehl GE; Marderstein AR; Gandara J; Perez AR; Withers DR; Targan SR; Shih DQ; Scherl EJ; Longman RS
    Immunity; 2018 Dec; 49(6):1077-1089.e5. PubMed ID: 30552020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-23 (IL-23), independent of IL-17 and IL-22, drives neutrophil recruitment and innate inflammation during Clostridium difficile colitis in mice.
    McDermott AJ; Falkowski NR; McDonald RA; Pandit CR; Young VB; Huffnagle GB
    Immunology; 2016 Jan; 147(1):114-24. PubMed ID: 26455347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ikaros Inhibits Group 3 Innate Lymphoid Cell Development and Function by Suppressing the Aryl Hydrocarbon Receptor Pathway.
    Li S; Heller JJ; Bostick JW; Lee A; Schjerven H; Kastner P; Chan S; Chen ZE; Zhou L
    Immunity; 2016 Jul; 45(1):185-97. PubMed ID: 27438771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ILC3-derived OX40L is essential for homeostasis of intestinal Tregs in immunodeficient mice.
    Deng T; Suo C; Chang J; Yang R; Li J; Cai T; Qiu J
    Cell Mol Immunol; 2020 Feb; 17(2):163-177. PubMed ID: 30760919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Nutrient-sensing Receptor GPRC6A in Regulating Colonic Group 3 Innate Lymphoid Cells and Inflamed Mucosal Healing.
    Hou Q; Huang J; Xiong X; Guo Y; Zhang B
    J Crohns Colitis; 2022 Aug; 16(8):1293-1305. PubMed ID: 35134872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD1d-Dependent iNKT Cells Control DSS-Induced Colitis in a Mouse Model of IFNγ-Mediated Hyperinflammation by Increasing IL22-Secreting ILC3 Cells.
    Park HJ; Lee SW; Van Kaer L; Hong S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-23 activates innate lymphoid cells to promote neonatal intestinal pathology.
    Chen L; He Z; Slinger E; Bongers G; Lapenda TLS; Pacer ME; Jiao J; Beltrao MF; Soto AJ; Harpaz N; Gordon RE; Ochando JC; Oukka M; Iuga AC; Chensue SW; Blander JM; Furtado GC; Lira SA
    Mucosal Immunol; 2015 Mar; 8(2):390-402. PubMed ID: 25160819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.